Diastolic Heart Failure in the Elderly

Clinics in Geriatric Medicine

Volumn 23, Issue 1, 2007, Pages 83-106

  Kitzman, Dalane W ^a   Daniel, Kurt R ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPLERENONE; INOTROPIC AGENT; LOSARTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PERINDOPRIL; PLACEBO; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE EXACERBATION; ELDERLY CARE; EXERCISE TOLERANCE; FLUID RETENTION; HEALTH CARE COST; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERTENSION; MORTALITY; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK REDUCTION; STARLING LAW; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIOTONIC AGENTS; CLINICAL TRIALS; DIASTOLE; DIURETICS; HEART FAILURE, CONGESTIVE; HUMANS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33751200484     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2006.09.002     Document Type: Review

References (128)

1. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 98 21 (1998) 2282-2289
2. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 3 (2006) 251-259
3. Ramachandran S., Vasan R.S., Larson M.G., et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction. J Am Coll Cardiol 33 7 (1999) 1948-1955
4. Kitzman D.W., Gardin J.M., Gottdiener J.S., et al. Importance of heart failure with preserved systolic function in patients ≥65 Years of Age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol 87 4 (2001) 413-419
5. Gottdiener J.S., McClelland R., Marshall R.J., et al. Outcome of congestive heart failure in elderly persons: Influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 137 8 (2002) 631-639
6. Devereux R.B., Roman M.J., Liu J.E., et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol 86 10 (2000) 1090-1096
7. Kupari M., Lindroos M., Iivanainen A.M., et al. Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med 241 (1997) 387-394
8. Masoudi F.A., Havranek E.P., Smith G., et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41 2 (2003) 217-223
9. Havranek E.P., Masoudi F.A., Westfall K.A., et al. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J 143 3 (2002) 412-417
10. Gottdiener J.S., Arnold A.M., Aurigemma G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35 6 (2000) 1628-1637
11. Samuel R.S., Hausdorff J.M., and Wei J.Y. Congestive heart failure with preserved systolic function: Is it a woman's disease?. Womens Health Issue 9 (1999) 219-222
12. Gerdts E., Zabalgoitia M., Bjornstad H., et al. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol 87 8 (2001) 980-983
13. Kane G.C., Hauser M.F., Behrenbeck T.R., et al. Impact of gender on rest Tc-99m sestamibi-gated left ventricular ejection fraction. Am J Cardiol 89 10 (2002) 1238-1241
14. Bella J.N., Palmieri V., Kitzman D.W., et al. Gender difference in diastolic function in hypertension (the HyperGEN study). Am J Cardiol 89 9 (2002) 1052-1056
15. Bella J.N., Wachtell K., Palmieri V., et al. Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Losartan Intervention For Endpoint Reduction in Hypertension Study. J Hypertens 19 1 (2001) 127-134
16. Douglas P.S., Katz S.E., Weinberg E.O., et al. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J Am Coll Cardiol 32 4 (1998) 1118-1125
17. Aurigemma G.P., Silver K.H., McLaughlin M., et al. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol 74 8 (1994) 794-798
18. Aurigemma G.P., Gaasch W.H., McLaughlin M., et al. Reduced left ventricular systolic pump performance and depressed myocardial contractile function in patients >65 years of age with normal ejection fraction and a high relative wall thickness. Am J Cardiol 76 10 (1995) 702-705
19. Mendes L.A., Davidoff R., Cupples L.A., et al. Congestive heart failure in patients with coronary artery disease: the gender paradox. Am Heart J 134 2 Pt 1 (1997) 207-212
20. Freshour J.R., Chase S.E., and Vikstrom K.L. Gender differences in cardiac ACE expression are normalized in androgen-deprived male mice. Am J Physiol Heart Circ Physiol 283 5 (2002) H1997-H2003
21. Rich M.W., and Kitzman D.W. Heart failure in octogenarians: a fundamentally different disease. Am J Geriatr Cardiol 9 Suppl 5 (2000) 97-104
22. Ogawa T., Spina R.J., Martin W.H., et al. Effect of aging, sex, and physical training on cardiovacular responses to exercise. Circulation 86 (1992) 494-503
23. Spina R.J., Ogawa T., Miller T.R., et al. Effect of exercise training on left ventricular performance in older women free of cardiopulmonary disease. Am J Cardiol 71 (1993) 99-194
24. Sullivan M., Cobb F.R., Knight J.D., et al. Stroke volume increases by similar mechanisms in men and women. Am J Cardiol 67 (1991) 1405-1412
25. Kitzman D.W., Little W.C., Brubaker P.H., et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 288 17 (2002) 2144-2150
26. Kitzman D.W., Higginbotham M.B., Cobb F.R., et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol 17 (1991) 1065-1072
27. Brubaker P.H., Joo K.C., Stewart K.P., et al. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil 26 2 (2006) 86-89
28. Hundley W.G., Kitzman D.W., Morgan T.M., et al. Cardiac cycle dependent changes in aortic area and aortic distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 38 3 (2001) 796-802
29. Little W.C. Enhanced load dependence of relaxation in heart failure: clinical implications. Circulation 85 6 (1992) 2326-2328
30. Gelpi R.J. Changes in diastolic cardiac function in developing and stable perinephritic hypertension in conscious dogs. Circ Res 68 (1991) 555-567
31. Shannon R.P., Komamura K., Gelpi R.J., et al. Altered load: an important component of impaired diastolic function in hypertension and heart failure. In: Lorell B.H., and Grossman W. (Eds). Diastolic relaxation of the heart (1994), Kluwer Academic Publishers, Norwell, Massachusetts 177-185
32. Little W.C. Assessment of normal and abnormal cardiac function. In: Braunwald E., Zipes D.P., and Libby P. (Eds). Heart disease (2001), W.B. Saunders Company, Philadelphia 479-502
33. Hoit B.D., and Walsh R.A. Diastolic dysfunction in hypertensive heart disease. In: Gaasch W.H., and LeWinter M.M. (Eds). Left ventricular diastolic dysfunction and heart failure (1994), Lea & Febiger, Philadelphia 354-372
34. Little W.C., Ohno M., Kitzman D.W., et al. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 92 (1995) 1933-1939
35. Iriarte M., Murga N., Morillas M., et al. Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension. Am J Cardiol 71 (1993) 308-312
36. Iriarte M.M., Perez O.J., Sagastagoitia D., et al. Congestive heart failure due to hypertensive ventricular diastolic dysfunction. Am J Cardiol 76 13 (1995) 43D-47D
37. Cohen-Solal A., Desnos M., Delahaye F., et al., for the Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology tNCoGHCatFGS. A national survey of heart failure in French hospitals. Eur Heart J 21 (2000) 763-769
38. Kramer K., Kirkman P., Kitzman D.W., et al. Flash pulmonary edema: association with hypertension, recurrence despite coronary revascularization. Am Heart J 140 3 (2000) 451-455
39. Gandhi S.K., Powers J.E., Fowle K.M., et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 344 1 (2000) 17-22
40. Clarkson P.B.M., Wheeldon N.M., MacFadyen R.J., et al. Effects of brain natriuretic peptide on exercise hemodynamics and neurohormones in isolated diastolic heart failure. Circulation 93 (1996) 2037-2042
41. Bella J.N., Palmieri V., Liu J.E., et al. Relationship between left ventricular diastolic relaxation and systolic function in hypertension: the hypertension genetic epidemiology network (hypergen) study. Hypertension 38 3 (2001) 424-428
42. Arnett D.K., Hong Y., Bella J., et al. Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN Study. Am J Hypertens 14 12 (2001) 1226-1230
43. Tang W., Arnett D.K., Devereux R.B., et al. Linkage of left ventricular diastolic peak filling velocity to chromosome 5 in hypertensive African Americans: the HyperGEN echocardiography study. Am J Hypertens 15 7 Pt 1 (2002) 621-627
44. Vikstrom K.L., and Leinwand L.A. The molecular genetic basis of familial hypertrophic cardiomyopathy. Heart Fail 11 1 (1995) 5-14
45. Webster K.A., and Bishopric N.H. Molecular aspects and gene therapy prospects for diastolic failure. Cardiol Clin 18 3 (2000) 621-635
46. Ghali J.K., Kadakia S., Cooper R., et al. Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure. Am J Cardiol 67 (1991) 1002-1006
47. Aronow W.S., Ahn C., and Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest 113 4 (1998) 867-869
48. Nagueh S.F., Middleton K.J., Kopelen H.A., et al. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 30 6 (1997) 1527-1533
49. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 19 (1998) 990-1003
50. Vasan R.S., and Levy D. Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 101 17 (2000) 2118-2121
51. Zile M.R., Gaasch W.H., Carroll J.D., et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?. Circulation 104 7 (2001) 779-782
52. Zile M.R., Baicu C.F., and Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350 19 (2004) 1953-1959
53. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 105 11 (2002) 1387-1393
54. Zile M.R., and Brutsaert D.L. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105 12 (2002) 1503-1508
55. Redfield M.M. Understanding "diastolic" heart failure. N Engl J Med 350 19 (2004) 1930-1931
56. Kitzman D.W. Heart failure and cardiomyopathy. In: Abrams W.B., Beers M.H., and Berkow B. (Eds). The Merck manual of geriatrics (2000), Merck Research Laboratories, Whitehouse Station, NJ 900-914
57. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., et al. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 5 (2002) 976-982
58. Davis K.M., Fish L.C., Minaker K.L., et al. Atrial natriuretic peptide levels in the elderly: differentiating normal aging changes from disease. J Gerontol 51A (1996) M95-M101
59. Pernenkil R., Vinson J.M., Shah A.S., et al. Course and prognosis in patients ≥ 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 79 2 (1997) 216-219
60. Vinson J.M., Rich M.W., Sperry J.C., et al. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 38 (1990) 1290-1295
61. Rich M.W., Vinson J.M., Sperry J.C., et al. Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study. J Gen Intern Med 8 (1993) 585-590
62. Kitzman D.W. Heart failure in the elderly: systolic and diastolic dysfunction. Am J Geriatr Cardiol 5 (1995) 20-26
63. Schocken D.D., Arrieta M.I., Leaverton P.E., et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 20 (1992) 301-306
64. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med 159 1 (1999) 29-34 [see comments]
65. Taffet G.E., Teasdale T.A., Bleyer A.J., et al. Survival of elderly men with congestive heart failure. Age Ageing 21 (1992) 49-55
66. Aronow W.S., Ahn C., and Kronzon I. Prognosis of congestive heart failure in elderly patients with normal versus abnormal left ventricular systolic function associated with coronary artery disease. Am J Cardiol 66 (1990) 1257-1259
67. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 3 (2006) 260-269
68. Aurigemma G.P. Diastolic heart failure-a common and lethal condition by any name. N Engl J Med 355 3 (2006) 308-310
69. Opasich C., Tavazzi L., Lucci D., et al. Comparison of one-year outcome in women versus men with chronic congestive heart failure. Am J Cardiol 86 3 (2000) 353-357
70. Kitzman D.W. Therapy for diastolic heart failure: on the road from myths to multicenter trials. J Card Fail 7 3 (2001) 229-231
71. Vasan R.S., and Benjamin E.J. Diastolic heart failure-no time to relax. N Engl J Med 344 1 (2001) 56-59
72. Tresch D.D., and McGough M.F. Heart failure with normal systolic function: a common disorder in older people. J Am Geriatr Soc 43 (1995) 1035-1042
73. Dauterman K., Massie B.M., and Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J 135 6 Pt 2 (1998) S310-S317
74. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 guidelines for the diagnosis and management of chronic heart failure in the adult. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 6 (2005) e1-e82
75. Lewis J.F., and Maron B.J. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥ 65 years of age. Am J Cardiol 73 (1994) 1105-1111
76. Lewis J.F., and Maron B.J. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life. J Am Coll Cardiol 13 (1989) 36-45
77. Olson L.J., Gertz M.A., Edwards W.D., et al. Senile cardiac amyloidosis with myocardial dysfunction. Diagnosis by endomyocardial biopsy and immunohistochemistry. N Engl J Med 317 (1987) 738-742
78. Moser M., and Hebert P.R. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 27 (1996) 1214-1218
79. Amery A., Birkenhager W., Brixko P., et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet I 8442 (1985) 1349-1354
80. Dahlof B., Lindholm L., Hannson L., et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 338 (1991) 1281-1285
81. Stassen J.A., Fagard R., Thijs L., et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 350 (1997) 757-764
82. Gong L.S., Zhang W., and Zhu Y. Shanghai Trial of Nifedipine in the Elderly (STONE). J Hypertens 14 (2001) 1237-1245
83. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 23 (2002) 2981-2997
84. Kitzman D.W. Diastolic dysfunction in the elderly: genesis and diagnostic and therapeutic implications. In: Kovacs S.J. (Ed). Cardiology Clinics of North America-Diastolic Function (2000), W.B. Saunders, Philadelphia 597-617
85. Stewart S., Marley J.E., and Horowitz J.D. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 354 9184 (1999) 1077-1083
86. Rich M.W., Beckham V., Wittenberg C., et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333 (1995) 1190-1195
87. Stewart S., Vanderheyden M., Pearson S., et al. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med 159 3 (1999) 257-261
88. Tsuyuki R.T., McKelvie R.S., Arnold J.M., et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med 161 19 (2001) 2337-2342
89. Bryson C.L., Mukamal K.J., Mittleman M., et al. The association between alcohol consumption and incident heart failure: the Cardiovascular Health Study. J Am Coll Cardiol 48 (2006) 305-311
90. Leier C.V., Dei Cas L., and Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 128 (1994) 564-574
91. Ahmed A., Rich M.W., Fleg J.L., et al. Effects of digoxin on morbidity and mortality in diastolic heart failure. The Ancillary Digitalis Investigation Group Trial. Circulation 114 (2006) 397-403
92. Lorell B.H., and Grossman W. Cardiac hypertrophy: the consequences for diastole. J Am Coll Cardiol 9 (1987) 1189-1193
93. Lorell B.H. Cardiac renin-angiotensin system in cardiac hypertrophy and failure. In: Lorell B.H., and Grossman W. (Eds). Diastolic relaxation of the heart. 2nd edition (1996), Kluwer Academic Publishers, Norwell, Massachusetts 91-99
94. Oren S., Grossman E., and Frohlich E.D. Reduction in left ventricular mass in patients with systemic hypertension treated with Enalapril, Lisinopril, or Fosinopril. Am J Cardiol 77 (1996) 93-96
95. Friedrich S.P., Lorell B.H., Douglas P.S., et al. Intracardiac ACE inhibition improves diastolic distensibility in patients with left ventricular hypertrophy due to aortic stenosis. Circulation 86 suppl I (1992) I-119
96. Lakatta E. Cardiovascular aging research: The next horizons. J Am Geriatr Soc 47 (1999) 613-625
97. Aronow W.S., and Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 71 (1993) 602-604
98. Philbin E.F., and Rocco T.A. Use of angiotensin-converting enzyme inhibitors in heart failure with preserved left ventricular systolic function. Am Heart J 134 2 (1997) 188-195
99. Philbin E.F., Rocco Jr. T.A., Lindenmuth N.W., et al. Clinical outcomes in heart failure: report from a community hospital-based registry. Am J Med 107 6 (1999) 549-555
100. Cleland J.G., Tendera M., Adamus J., et al. Perindopril for elderly people with chronic heart failure: the PEP-CHF study. The PEP investigators. Eur J Heart Fail 1 3 (1999) 211-217 [see comments]
101. Abraham T.P., Kon N.D., Nomeir A.M., et al. Accuracy of transesophageal echocardiography in preoperative determination of aortic anulus size during valve replacement. J Am Soc Echocardiogr 10 (1997) 149-154
102. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 9386 (2003) 777-781
103. Vandenberg V.F., Rath L.S., Stuhlmuller P., et al. Estimation of left ventricular cavity area with on-line, semiautomated echocardiographic edge detection system. Circulation 86 (1992) 159-166
104. Bonow R.O., Leon M.B., Rosing D.R., et al. Effects of verapamil and propranolol on left ventricular systolic function and diatsolic filling in patients with coronary artery disease: radionuclide angiographic studies at rest and during exercise. Circulation 65 (1981) 1337-1350
105. Bonow R.O., Dilsizian V., Rosing D.R., et al. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 72 (1985) 853-864
106. Udelson J., and Bonow R.O. Left ventricular diastolic function and calcium channel blockers in hypertrophic cardiomyopathy. In: Gaasch W.H. (Ed). Left ventricular diastolic dysfunction and heart failure (1996), Lea & Febiger, Malvern, Pennsylvania 465-489
107. Serizawa T., Shin-Ichi M., Nagai Y., et al. Diastolic abnormalities in low-flow and pacing tachycardia-induced ischemia in isolated rat hearts-modification by calcium antagonists. In: Lorell B.H., and Grossman W. (Eds). Diastolic relaxation of the heart (1996), Kluwer Academic Publishers, Norwell, Massachusetts 266-274
108. Cheng C.P., Pettersson K., and Little W.C. Effects of felodipine on left ventricular systolic and diastolic performance in congestive heart failure. J Pharma and Exper Thera 271 (1994) 1409-1417
109. Cheng C.P., Noda T., Ohno M., et al. Differential effects of enalaprilat and felodipine on diastolic function during exercise in dogs with congestive heart failure. Circulation 88 4 (1993) I-294
110. Little W.C., Cheng C.P., Elvelin L., et al. Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: focus on felodipine. Cardiovasc Drugs Ther 9 5 (1995) 657-663
111. Ten Cate F.J., Serruys P.W., Mey S., et al. Effects of short-term administration of verapamil on left ventricular filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy. Circulation 68 6 (1983) 1274-1279
112. Hess O.M., Murakami T., and Krayenbuehl H.P. Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy?. Circulation 74 (1996) 530-543
113. Brutsaert D.L., Rademakers F., Sys S.U., et al. Analysis of relaxation in the evaluation of ventricular function of the heart. Prog Cardiovasc Dis 28 (1985) 143-163
114. Brutsaert D.L., Sys S.U., and Gillebert T.C. Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 22 (1993) 318-325
115. Setaro J.F., Zaret B.L., Schulman D.S., et al. Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance. Am J Cardiol 66 (1990) 981-986
116. Little W.C., Wesley-Farrington D.J., Hoyle J., et al. Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction. J Cardiovasc Pharmacol 43 2 (2004) 288-293
117. Sasayama S., Asanoi H., Ishizaka S., et al. Diastolic dysfunction in experimental heart failure. In: Lorell B.H., and Grossman W. (Eds). Diastolic relaxation of the heart (1994), Kluwer Academic Publishers, Norwell, Massachusetts 195-202
118. Copeland J.L., Consitt L.A., and Tremblay M.S. Hormonal responses to endurance and resistance exercise in females aged 19-69 years. J Gerontol A Biol Sci Med Sci 57 4 (2002) B158-B165
119. Udelson J., and Bonow R.O. Left ventricular diastolic function and calcium channel blockers in hypertrophic cardiomyopathy. In: Gaasch W.H., and LeWinter M.M. (Eds). Left ventricular diastolic dysfunction and heart failure (1994), Lea & Febiger, Philadelphia 462-489
120. Cheng C.P., Igarashi Y., and Little W.C. Mechanism of augmented rate of left ventricle filling during exercise. Circ Res 70 (1992) 9-19
121. Cheng C.P., Noda T., Nozawa T., et al. Effect of heart failure on the mechanism of exercise induced augmentation of mitral valve flow. Circ Res 72 (1993) 795-806
122. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341 10 (1999) 709-717
123. Pitt B., Reichek N., Willenbrock R., et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108 15 (2003) 1831-1838
124. Rajagopalan S., and Pitt B. Aldosterone as a target in congestive heart failure. Med Clin North Am 87 2 (2003) 441-457
125. Zannad F., Alla F., Dousset B., et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized Aldactone evaluation study (RALES). Rales Investigators. Circulation 102 22 (2000) 2700-2706
126. Daniel K.R., Wells G.L., Fray B., et al. The effect of spironolactone on exercise tolerance and quality of life in elderly women with diastolic heart failure. Am.J.Geriatr. Cardiol 12 2 (2003) 131
127. Mottram P.M., Haluska B., Leano R., et al. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 110 5 (2004) 558-565
128. Little W.C., Zile M.R., Kitzman D.W., et al. The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J Card Fail 11 3 (2005) 191-195